About Enhanced Capital
Enhanced Capital, established in 1999, is a private debt fund primarily based in New York City, United States. It specializes in financing Conventional Debt round of companies based in United States. Its portfolio includes 20 firms, spanning the Life Sciences, Enterprise Applications sectors.
As of Sep 2026, Enhanced Capital has witnessed 11 portfolio exits so far. Its most notable investments include companies like Precipio Diagnostics, Inbox Health and SciAps.
Its latest investment was a $3M Conventional Debt round in Mjh Fab on Nov 2023.
Key Metrics
Founded Year
1999
Location
New York City, United States
Portfolio Companies
Sectors of Investment
Stages of Investment
Conventional Debt, Series A & 5 more
Locations of Investment
Enhanced Capital's List of Top Investments
Enhanced Capital has a portfolio of 20 companies. Their most notable investments are in Alereon and Inscitech.Their portfolio spans across and United States. They have invested in Life Sciences, Enterprise Applications, High Tech and 12 other sectors, across stages such as Conventional Debt, Series A and 5 more. Here is the list of top investments by Enhanced Capital:Provider of cancer diagnostics and second opinion tools. The company uses ICE COLD-PCR technology to detect cancer mutations. The product includes SmartGen is a combination of diagnostic tools for the prognosis and diagnosis of cancer. SmartPath is a service that couples the patient and treating physician, with an academic expert for a second opinion. Results are generally provided within hours and customers can also request a live consultation with the pathologist. It also provides a HemeScreen Panel for screening hematologic malignancy.
Key facts about Precipio Diagnostics
- Founded Year: 1997
- Location: New Haven (United States)
- Annual Revenue: $10M - $50M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $800K
- Employee Count: 93 as on Jul 31, 2026
- Investors: Enhanced Capital, Connecticut Innovations and 3 Others
- Latest Funding Round: Post IPO, Oct 31, 2017, $*****
- Highlight: Public
2. Inbox Health
Inbox Health offers a cloud-based medical billing and payment management solution for healthcare companies. It features a data-driven platform that automates and personalizes the entire patient billing communication process. It creates practice management tools that improve revenue cycle management, insurance eligibility, patient balance estimates, and patient invoicing. It also offers digital insurance cards for patients to provide updates related to medical billing and payment transactions. The company covers insurance and benefits for healthcare organizations.
Key facts about Inbox Health
- Founded Year: 2014
- Location: New Haven (United States)
- Stage: Series B
- Total Funding till date: $68.4M
- Employee Count: 128 as on Jul 31, 2026
- Investors: Collab Fund, Ten Coves Capital and 16 Others
- Latest Funding Round: Conventional Debt, Sep 15, 2025, $*****
- Highlight: Editors' Pick
3. SciAps
Key facts about SciAps
- Founded Year: 2012
- Location: Andover (United States)
- Stage: Acquired
- Total Funding till date: $53.4M
- Employee Count: 124 as on Jul 31, 2026
- Investors: Gefinor Capital, Rand Capital and 8 Others
- Latest Funding Round: Series B, Jul 21, 2023, $*****
- Highlight: Acquired
4. BinOptics
BinOptics manufactures monolithically integrated optoelectronic components based on indium phosphide and other semiconductor materials. Its products include edge-emitting and surface-emitting Fabry Perot lasers, DFB lasers, and lasers with integrated monitoring photodiodes. It also develops custom integrated microphotonic solutions for optical systems and subsystems. BinOptics’ expertise is based around the so-called “etched facet technology” (EFT) process – a high-yielding lithographic method for making laser diodes on a variety of semiconductor materials. The company was acquired by Macom in 2014.
Key facts about BinOptics
- Founded Year: 2000
- Location: Ithaca (United States)
- Stage: Acquired
- Total Funding till date: $45.6M
- Employee Count: 15 as on Aug 31, 2026
- Investors: Gefinor Capital, Liberty Capital Ventures and 9 Others
- Latest Funding Round: Series D, Dec 27, 2012, $*****
- Highlight: Acquired
5. Alereon
Leader in ultrawideband (UWB) wireless solutions, eliminating wires in hi-tech products. The company designs and manufactures UWB chipsets, offering modules, reference designs, and custom hardware/software. They provide wireless solutions for high-speed, uncongested wireless needs across various industries. Their offerings include SDKs, evaluation kits, system engineering, and manufacturing support. They focus on custom solutions tailored to individual customer systems, leveraging their experienced engineering staff to solve complex problems. They provide technology for wireless communication, high speed data transfer, and real-time connectivity. Their solutions benefit sectors like consumer electronics, medical devices, and military applications.
Key facts about Alereon
- Founded Year: 2003
- Location: Austin (United States)
- Stage: Series B
- Total Funding till date: $95M
- Employee Count: 22 as on Aug 31, 2026
- Investors: Western Technology Investment, SK Telecom and 10 Others
- Latest Funding Round: Series B, Jun 05, 2012, $*****
- Highlight: Editors' Pick
Enhanced Capital's Year-on-Year Investment Trends
Enhanced Capital has invested in 20 companies over the last 24 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in Mjh Fab and most recent follow-on round was in iCleanse.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 0 | 0 |
2024 | 0 | 0 | 0 |
2023 | 1 | 1 | 2 |
2022 | 1 | 0 | 1 |
2021 | 0 | 0 | 0 |
2020 | 0 | 0 | 0 |
2019 | 0 | 0 | 0 |
2018 | 2 | 0 | 2 |
Enhanced Capital's Investments by Stage
Enhanced Capital has made 5 investments in Conventional Debt stage with an average round size of $2.25M, 4 investments in Series A stage with an average round size of $3.28M and 3 investments in Seed stage with an average round size of $1.25M.Stage of entry | No. of Investments |
|---|---|
Conventional Debt | 5 |
Series A | 4 |
Seed | 3 |
Series B | 2 |
Venture Debt | 2 |
Others | 2 |
Note: We have considered here, only first round of investments
Enhanced Capital's Investments by Sector
Enhanced Capital has a diverse portfolio, with companies operating in the Semiconductors, Chemicals and Materials, Enterprise Applications, High Tech and Life Sciences. Notably, it has invested in 10 Enterprise (B2B) companies, 9 Tech companies, 5 Software companies and at least 5 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Semiconductors | 3 |
Chemicals and Materials | 2 |
Enterprise Applications | 2 |
High Tech | 2 |
Life Sciences | 2 |
Others | 11 |
Note: We have considered here, only first round of investments
Enhanced Capital's Investments by Geography
Enhanced Capital has made most investments in United States (18).Enhanced Capital's recent investments
Enhanced Capital has not made any investment in 2026 so far.Here are the most recent investments by Enhanced Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Nov 2023 | United States | Conventional Debt | 1343 | - | |
Oct 06, 2023 | United States | Venture Debt | 2325 | - | |
Oct 10, 2022 | United States | Conventional Debt | 3342 | - | |
Jun 15, 2018 | United States | Series A | 8000 | ||
Feb 14, 2018 | United States | Seed | 4211 | - |
IPOs and Publicly Listed companies in Enhanced Capital's Portfolio
1 of Enhanced Capital's portfolio company became public - Precipio Diagnostics. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jul 2000.Here are Enhanced Capital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 21, 2000 | Oct 28, 2013 | Post IPO | 2120 |
Acquired companies in Enhanced Capital's Portfolio
10 companies from Enhanced Capital's portfolio have been acquired. The most recent acquisition was SciAps in Jul 2024 by Spectris for $*****.Here are Enhanced Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 04, 2024 | Jul 08, 2013 | Venture Debt | 2728 | |
Jun 27, 2023 | Dec 03, 2008 | Seed | 7584 | |
Mar 03, 2023 | Feb 14, 2018 | Seed | 1949 | |
Sep 09, 2020 | Oct 10, 2022 | Conventional Debt | 4586 | |
Sep 16, 2015 | Jun 03, 2013 | Seed | 7883 |
Co-investors of Enhanced Capital
Over the past 24 years, 58 investors have co-invested in Enhanced Capital's portfolio companies. This includes funds and angels.
- Invested before Enhanced Capital: Connecticut Innovations, LaunchCapital and 19 others have invested in rounds before Enhanced Capital. There are 3 companies where Connecticut Innovations has invested before Enhanced Capital and 2 companies where LaunchCapital has invested before Enhanced Capital.
- Top Co-investors of Enhanced Capital: 19 investors entered a company along with Enhanced Capital. These include investors like Advantage Capital (2 companies).
- Invested after Enhanced Capital: A total of 18 investors have invested in Enhanced Capital's portfolio after their investments. Top Investors include Healthy Ventures (1 company) and Commerce Ventures (1 company).
Recent News related to Enhanced Capital
•
•
•
•
•
•
Enhancing Capital LLC Makes New Investment in Moody's Co. (NYSE:MCO)MarketBeat•Mar 19, 2025•Moody's, Enhanced Capital
•
Enhancing Capital LLC Makes New $2.26 Million Investment in Visa Inc. (NYSE:V)MarketBeat•Mar 19, 2025•Visa, Enhanced Capital
•
Enhancing Capital LLC Invests $6.41 Million in Eli Lilly and Company (NYSE:LLY)MarketBeat•Mar 19, 2025•Lilly, Enhanced Capital
•
•
